Healthcare, Life Sciences & Pharmaceuticals
Opportunities in healthcare, life sciences & pharmaceuticals
The healthcare landscape is complex and has continued to evolve with the advancement of technology and artificial intelligence. Innovation across healthcare and life sciences has given rise to new treatments, pharmaceuticals, and a host of other capabilities available to hospitals and healthcare service providers. At the same time, demographic shifts and ageing populations are reshaping healthcare systems worldwide, with global healthcare spending expected to reach $20.5 trillion in 2050, up from $11.2 trillion today1.
Deep understanding of the evolving healthcare sector
Our Healthcare, Life Sciences & Pharmaceuticals Practice stands ready to provide clients with comprehensive, multidisciplinary advice that is both timely and practical across sub-specialty groups. Our Team is drawn from specialists in various corporate practice areas such as Mergers & Acquisitions, Cybersecurity, Intellectual Property, Insurance, and Litigation with deep and broad experience working on some of the most innovative and high-profile matters in healthcare.
With deep industry knowledge and a commercially focused approach, we support clients through every stage of growth and transformation. This includes advising on local or cross-border mergers & acquisitions, healthcare regulations and requirements, corporate reorganisation and restructuring, commercial agreements and contracts, establishment of healthcare infrastructure and other operational agreements.
Our Team is well positioned with extensive experience in advising healthcare, life sciences and pharmaceutical clients on complex healthcare-related disputes including professional liability disputes across the healthcare spectrum and IP infringement proceedings, tapping on our expertise in litigation and dispute resolution. We deeply understand the importance of resolving sensitive matters in an amicable, discreet, and timely manner, and are well placed to provide advice on handling intricate and highly complex situations.
Regionally relevant and practical advice
We also understand that the interconnectivity of our world means that some matters may take on a multi-jurisdictional nature. That is why our Healthcare, Life Sciences & Pharmaceuticals Practice is further supported by over 650 lawyers in more than 36 specialist practices across A&G Asia.
This enables our Team to assemble a multi-disciplinary task force composed of leading specialists in the jurisdictions involved. Clients can therefore be assured that in our ability to provide holistic advice that takes into consideration global best practices, industry leading corporate policies, and local regulatory nuances.
1 https://www.mckinsey.com/mhi/our-insights/the-health-of-nations-stronger-health-stronger-economies